Drug treats rare heart disease by silencing gene
A Phase 3 clinical trial of the investigational drug vutrisiran has shown that it can reduce the risk of death and recurring cardiovascular events in people with a specific heart condition...
A Phase 3 clinical trial of the investigational drug vutrisiran has shown that it can reduce the risk of death and recurring cardiovascular events in people with a specific heart condition...
The first patient in England to receive a personalised bowel cancer vaccine has been treated in a Birmingham hospital...
Semen microbiome composition has been associated with sperm abnormalities, in a study of men in the United States...
by Yan Lau
RNA-based vaccines for COVID-19 can be misread by the body, producing harmless off-target proteins, according to new research...
by Jake Knox
A new driver of ovarian development, contributing to sex-specific organ differences, has been identified...
The 2023 Nobel Prize in Physiology or Medicine has been awarded jointly to Professor Katalin Karikó and Professor Drew Weissman for their discoveries relating to nucleoside base modifications, which contributed to the development of mRNA vaccines...
The Science Museum's Injecting Hope: The race for a COVID-19 vaccine exhibition is a defence of science, writes Dr Semyon Bodian...
A chemically-modified DNA enzyme can be used to 'silence' a harmful gene mutation found in many types of cancers...
Stay up-to-date on all the latest developments in the fields of human fertility and genomics. And be the first to hear about upcoming events and other announcements.